Search research articles
Contact Us
Filters
Showing results (61-70 of 72) with videos related to
Page
of 8
Sort By:
Journal of the Academy of Consultation-Liaison Psychiatry
|
December 15, 2022
Major Depressive Disorder in an International Multisite Wilson Disease Registry
Michelle A Camarata, Aftab Ala, Ayse K Coskun, et al.
Journal of Medical Virology
|
April 10, 2020
Clinical performance of Determine HBsAg 2 rapid test for Hepatitis B detection
Ana Avellon, Aftab Ala, Antonio Diaz, et al.
Postgraduate Medical Journal
|
May 3, 2024
Use of UK faith Centre as a COVID-19 community vaccination clinic: exploring a potential model for community-based health care delivery
Helena Wehling, Dale Weston, Charlotte Hall, et al.
Orphanet Journal of Rare Diseases
|
November 11, 2025
Management of Wilson disease across Europe: an international physician-oriented survey by the ERN-RARE Liver group
Frederik Teicher Kirk, Karina Stubkjær Rewitz, Zoe Mariño, et al.
JHEP Reports : Innovation in Hepatology
|
March 14, 2026
Evaluation of novel assays of non-ceruloplasmin copper to monitor chelation treatment in patients with Wilson disease: Monitoring chelation treatment in Wilson disease
Peter Ott, Thomas Sandahl, Aftab Ala, et al.
Rheumatology (Oxford, England)
|
December 28, 2018
Recommendations for the management of secondary hypogammaglobulinaemia due to B cell targeted therapies in autoimmune rheumatic diseases
Sonali Wijetilleka, David R Jayne, Chetan Mukhtyar, et al.
The Lancet. Gastroenterology & Hepatology
|
October 2, 2022
Trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE): a randomised, open-label, non-inferiority, phase 3 trial
Michael L Schilsky, Anna Czlonkowska, Massimo Zuin, et al.
JHEP Reports : Innovation in Hepatology
|
August 14, 2024
Non-ceruloplasmin copper and urinary copper in clinically stable Wilson disease: Alignment with recommended targets
Peter Ott, Thomas Sandahl, Aftab Ala, et al.
Plos One
|
January 23, 2023
Utility of a buccal swab point-of-care test for the IFNL4 genotype in the era of direct acting antivirals for hepatitis C virus
Aminata Sy, Leanne McCabe, Emma Hudson, et al.
Wellcome Open Research
|
August 19, 2021
Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C
Graham S Cooke, Sarah Pett, Leanne McCabe, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 72) with videos related to
Sort By:
Page
of 8
Journal of the Academy of Consultation-Liaison Psychiatry
|
December 15, 2022
Major Depressive Disorder in an International Multisite Wilson Disease Registry
Michelle A Camarata, Aftab Ala, Ayse K Coskun, et al.
Journal of Medical Virology
|
April 10, 2020
Clinical performance of Determine HBsAg 2 rapid test for Hepatitis B detection
Ana Avellon, Aftab Ala, Antonio Diaz, et al.
Postgraduate Medical Journal
|
May 3, 2024
Use of UK faith Centre as a COVID-19 community vaccination clinic: exploring a potential model for community-based health care delivery
Helena Wehling, Dale Weston, Charlotte Hall, et al.
Orphanet Journal of Rare Diseases
|
November 11, 2025
Management of Wilson disease across Europe: an international physician-oriented survey by the ERN-RARE Liver group
Frederik Teicher Kirk, Karina Stubkjær Rewitz, Zoe Mariño, et al.
JHEP Reports : Innovation in Hepatology
|
March 14, 2026
Evaluation of novel assays of non-ceruloplasmin copper to monitor chelation treatment in patients with Wilson disease: Monitoring chelation treatment in Wilson disease
Peter Ott, Thomas Sandahl, Aftab Ala, et al.
Rheumatology (Oxford, England)
|
December 28, 2018
Recommendations for the management of secondary hypogammaglobulinaemia due to B cell targeted therapies in autoimmune rheumatic diseases
Sonali Wijetilleka, David R Jayne, Chetan Mukhtyar, et al.
The Lancet. Gastroenterology & Hepatology
|
October 2, 2022
Trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE): a randomised, open-label, non-inferiority, phase 3 trial
Michael L Schilsky, Anna Czlonkowska, Massimo Zuin, et al.
JHEP Reports : Innovation in Hepatology
|
August 14, 2024
Non-ceruloplasmin copper and urinary copper in clinically stable Wilson disease: Alignment with recommended targets
Peter Ott, Thomas Sandahl, Aftab Ala, et al.
Plos One
|
January 23, 2023
Utility of a buccal swab point-of-care test for the IFNL4 genotype in the era of direct acting antivirals for hepatitis C virus
Aminata Sy, Leanne McCabe, Emma Hudson, et al.
Wellcome Open Research
|
August 19, 2021
Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C
Graham S Cooke, Sarah Pett, Leanne McCabe, et al.
Page
of 8